LBPMedicine(SH:688393) Shang Hai Zheng Quan Bao·2025-10-27 23:15Core Viewpoint - The company, Guangzhou Anbiping Pharmaceutical Technology Co., Ltd., has announced significant changes to its corporate governance structure, including the cancellation of the supervisory board and certain specialized committees of the board, aimed at optimizing management processes and enhancing decision-making efficiency [8][9][10]. Financial Data - The quarterly financial report for the third quarter has not been audited, and the company has provided key financial data and indicators in RMB [3]. - The report indicates that there were no significant non-recurring gains or losses recognized during the reporting period [4]. Corporate Governance Changes - The company has decided to abolish the supervisory board and its rules to streamline governance and improve internal supervision, with responsibilities being integrated into the audit committee of the board [8]. - Several specialized committees of the board, including the strategy committee, nomination committee, and remuneration and assessment committee, have been canceled, with their functions being reassigned to the board and independent directors [9]. - Amendments to the company's articles of association have been proposed to align with the latest legal and regulatory requirements, enhancing governance standards [10].